Zydus wins USFDA approval for Ascorbic Acid Injection

Zydus wins USFDA approval for Ascorbic Acid Injection. The company announced final approval for its injectable vitamin C product with 180-day CGT exclusivity, boosting its US generics portfolio. This exclusivity may delay rival approvals, enhancing near-term revenue potential. The development strengthens Zydus’s position in the competitive USFDA-regulated market.

📊 STOCKS: $ZYDUSLIFE | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #USFDA